Last week, the U.S. Food and Drug Administration (FDA) issued two significant draft guidance documents concerning the use of artificial intelligence (AI) in medical devices and in drug and biological product development....more
1/16/2025
/ Artificial Intelligence ,
Bias ,
Biologics ,
Draft Guidance ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Medical Devices ,
Premarket Approval Applications ,
Product Development Protocols ,
Regulatory Requirements ,
Risk Management ,
Software ,
Transparency
On May 17, 2024, Governor Jared Polis signed into law Colorado Senate Bill 24-205 (SB205), pioneering a comprehensive regulatory framework for artificial intelligence (AI) systems....more
5/31/2024
/ Artificial Intelligence ,
Compliance ,
Enforcement Authority ,
Exemptions ,
Governor Polis ,
New Legislation ,
NIST ,
Regulatory Oversight ,
Regulatory Standards ,
Risk Management ,
Software Developers ,
State Attorneys General ,
Technology Sector ,
Unfair or Deceptive Trade Practices
In recent months, artificial intelligence (AI) has taken center stage as the technology to watch, with generative AI systems like ChatGPT exciting companies, fascinating journalists, and concerning people in governance and...more